top of page
< Back

Is Hers Legit? What to Know Before Ordering

FAQ-000042

Direct Answer

Hers is a real, legitimate telehealth company, it's the women-focused brand within Hims & Hers Health, Inc. (NYSE: HIMS), a publicly traded company, LegitScript certified, founded in 2018. It is not a scam in the sense of a fake operation. That said, it carries a notably lower Trustpilot rating (3.4 out of 5 across over 6,200 reviews) than most GLP-1 telehealth companies covered in this library, and there is a specific, documented complaint pattern worth knowing before you order: customers requesting a GLP-1 medication specifically and instead being shipped Hers's separate oral "medication kit," which may contain metformin, bupropion, topiramate, vitamin B12, and naltrexone, a different medication combination, not a GLP-1 at all, without clear explanation for the substitution.

What Hers Actually Offers

Hers offers two distinct paths, and it's important not to confuse them: compounded semaglutide injections, starting around $199/month with a 6 to 12 month prepaid commitment, and oral "medication kits," starting around $69/month with a 5 to 10 month commitment, which are not necessarily semaglutide or tirzepatide at all, they may instead combine other prescription medications (metformin, bupropion, topiramate, naltrexone) that work through different mechanisms than GLP-1 receptor agonists. Brand-name options including Ozempic, Wegovy, and Mounjaro are also available at standard list pricing, without the discount seen on compounded options.

The Specific Complaint Pattern Worth Knowing

Multiple independent reviews describe customers who specifically requested and paid for a GLP-1 medication receiving the non-GLP-1 oral kit instead, with limited or no explanation offered when questioned. Separately, a recurring complaint pattern involves automatic subscription renewal and shipment without an advance warning or reminder, followed by difficulty reaching support or canceling before the next charge processes. This is a different, more concerning pattern than the general customer-service-delay complaints seen at most other companies reviewed in this library, it specifically concerns getting a different product than what was requested and paid for.

What's Genuinely Reassuring

Hers is publicly traded, which brings real regulatory oversight and financial audits that smaller telehealth startups don't have. Its compounded medications are sourced from FDA-registered compounding pharmacies, and it does employ licensed U.S. providers. Anti-nausea medication is included at no extra charge when prescribed, and the platform includes 24/7 provider messaging and habit-tracking tools.

A Practical Recommendation

If you're specifically seeking a GLP-1 medication through Hers, confirm in writing during your intake that you're being prescribed an actual GLP-1 (semaglutide or tirzepatide), not the separate oral medication kit, before completing any prepaid, multi-month commitment. Given the documented pattern of unclear substitutions, this single confirmation step is worth the extra effort.

Standard Compounded-Drug Caveats Still Apply

For Hers's compounded semaglutide path specifically, the standard caveats on our Compounded Semaglutide page apply, not FDA-approved as a finished product.

References

  • ConsumerAffairs: Hers Reviews from Real Customers
  • WVU Healthcare: Hers Weight Loss Reviews 2026, Pricing, Results and Verdict
  • U.S. News & World Report: Hers Weight Loss Review 2026

Related Resources

Related Articles

Explore More

Explore the full GLP-1 Tracker knowledge base on DietApp.com

Get Started

Explore the GLP-1 Tracker knowledge base for accurate, sourced information on every GLP-1 option.

About DietApp.com

DietApp.com combines evidence-based GLP-1 medication education with practical treatment tracking tools. This article is for general informational purposes and is not medical or legal advice. Company reputations and reviews can change, verify current details directly before making any purchasing decision.

is-hers-glp-1-legit

bottom of page